Showing results (131-140 of 217) with videos related to

Sort By:
Pageof 22
Japanese Journal of Clinical Oncology|May 11, 2006
Phase I/II study of oxaliplatin with weekly bolus fluorouracil and high-dose leucovorin (ROX) as first-line therapy for patients with colorectal cancerYasuhide Yamada, Atsushi Ohtsu, Narikazu Boku, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|April 20, 2011
A phase II study of biweekly mitomycin C and irinotecan combination therapy in patients with fluoropyrimidine-resistant advanced gastric cancer: a report from the Gastrointestinal Oncology Group of the Japan Clinical Oncology Group (JCOG0109-DI Trial)Tetsuya Hamaguchi, Kuniaki Shirao, Atsushi Ohtsu, et al.
Surgery Today|November 14, 2015
Feasibility of neoadjuvant S-1 and oxaliplatin followed by surgery for resectable advanced gastric adenocarcinomaYoshitaka Honma, Yasuhide Yamada, Tetsuji Terazawa, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|August 3, 2017
A phase II study of combination therapy with oral S-1 and cisplatin in elderly patients with advanced gastric cancerYusuke Sasaki, Satoru Iwasa, Shunsuke Okazaki, et al.
The British Journal of Radiology|June 20, 2018
Imaging peritoneal metastasis of gastric cancer with 18F-fluorothymidine positron emission tomography/computed tomography: a proof-of-concept studyYoshitaka Honma, Takashi Terauchi, Ukihide Tateishi, et al.
ESMO Open|August 21, 2020
Phase II study of lenvatinib for metastatic colorectal cancer refractory to standard chemotherapy: the LEMON study (NCCH1503)Satoru Iwasa, Natsuko Okita, Aya Kuchiba, et al.
Anticancer Research|April 12, 2015
Bevacizumab and postoperative wound complications in patients with liver metastases of colorectal cancerHirofumi Utsumi, Yoshitaka Honma, Kengo Nagashima, et al.
Anticancer Research|March 9, 2012
Phase I study of sunitinib plus modified FOLFOX6 in Japanese patients with treatment-naive colorectal cancerTakayuki Yoshino, Kentaro Yamazaki, Tetsuya Hamaguchi, et al.
Oncology|December 3, 2011
Phase II study of bolus 5-fluorouracil and leucovorin combined with weekly paclitaxel as first-line therapy for advanced gastric cancerJunichi Matsubara, Yasuhiro Shimada, Ken Kato, et al.
International Journal of Cancer|July 23, 2011
Pharmacokinetic parameters from 3-Tesla DCE-MRI as surrogate biomarkers of antitumor effects of bevacizumab plus FOLFIRI in colorectal cancer with liver metastasisYoshinori Hirashima, Yasuhide Yamada, Ukihide Tateishi, et al.
Pageof 22